GenomicsVisions Blog

Observations of an industry veteran

Category: General

Served Market – careful what you count!

Why would you want to define a served market?

The served market may be a part (even a single segment) of the life science research market for instance “Genomics” or “Proteomics” or “Diagnostic assay development” are, in many ways, three distinct areas. Maybe the products required overlap, as do the research practices, but the research focus is different. However, as an example, within Genomics and Proteomics the question may well be the same. To exacerbate this large companies also operate in various served markets. So when they report their results in the annual report both company A and B may well claim leadership in a particularly nebulous market.

Take for instance In Vitro Diagnostics (IVD) – a market worth over $80bn!. Yet the leaders claim leadership with, in some years, with wildly different market shares claims.  Oddly both could be correct in their assertions depending on how they define the IVD market. Did company A include blood collection systems (pre-analytical)? Maybe not because they do no serve that market, thus inflating share, whereas company B may well do and have included it in their definition of IVD. improving their own share. So whilst blindingly obvious, share claim comparisons can only be made on definitions of the same market.

Yet, entrepreneurs with their business plan tucked under their arm will take the first data set they come across and that will be only market research they will do. Not a good start for measuring expectations when results don’t come.

So the message is understand what it is you’re defining and what you’re measuring!

The thorny world of tech transfer

Why is the process of tech transfer (TT) from a university into something worthwhile say a product or license so fraught with difficulties?

The politics involved just stagger me. Also I am amazed at the standard of skills that individuals charged with such a task possess, it is appalling. People with little scientific knowledge, no commercial experience, lack of market understanding, inept deal negotiators litter the world of TT. Thus the UK (as usual) falls behind and is obsessed with “impact”…it is a joke!

What say you?